盟科药业跌10.96% 光大证券2天前给予维持买入评级

Group 1 - The core viewpoint of the article highlights that Mengke Pharmaceutical (688373.SH) experienced a significant decline in stock price, closing at 8.61 yuan with a drop of 10.96% [1] - Everbright Securities analysts Wang Mingrui and Ye Si'ao published a report on September 23, maintaining a "buy" rating for the company, emphasizing the positive impact of Haiqing Pharmaceutical's billion yuan capital increase on the company's research, sales, and production across the entire chain [1]